C4 Therapeutics, Inc. (CCCC) NASDAQ
2.92
+0.09(+3.18%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.92
+0.09(+3.18%)
Currency In USD
| Market Cap | 158.33M |
| Enterprise Value | 143.71M |
| P/E Ratio | -2.31 |
| PEG Ratio | -0.37 |
| Price/Sales Ratio | 6.73 |
| Price/Book Ratio | 0.94 |
| Enterprise/Revenue | 6.32 |
| Enterprise/EBITDA | -2.1 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -2.92 |
| Operating Margin | -3.21 |
| Return On Assets | -0.29 |
| Return On Equity | -0.54 |
| Revenue | 35.95M |
| Revenue/Share | 0.43 |
| Gross Profit | 27.97M |
| EBITDA | -102.91M |
| Net Income | -104.99M |
| Diluted EPS | -1.27 |
| Total Cash | 248.54M |
| Total Cash/Share | 3 |
| Total Debt | 59.98M |
| Total Debt/Equity | 0.23 |
| Current Ratio | 7.81 |
| Book Value Per Share | 3.1 |
| 52-Week Change | 80.25 |
| 52-Week High | 3.82 |
| 52-Week Low | 1.21 |
| Moving Average 50 Days | 2.79 |
| Moving Average 200 Days | 2.45 |
| Average Volume | 2.67M |
| Shares Outstanding | 82.83M |
| % Held by Institutions | 110.01 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |